Pfizer的股票在高收入下看到混合活动,但收入却在下降,被评为“多价购买”。 Pfizer's stock sees mixed activity amid strong earnings but falling revenue, rated a "Moderate Buy."

Pfizer公司看到其股份被Insight顾问公司和Procyon顾问公司等投资公司购买,而其他公司如联盟财富顾问公司出售了一些股份。 Pfizer Inc. saw its shares bought by investment firms like Insight Advisors and Procyon Advisors, while others like Alliance Wealth Advisors sold some holdings. Pfizer报告,其丰厚收入为每股0.92美元,超过估计数,尽管其收入与去年相比下降了7.8%。 Pfizer reported strong earnings of $0.92 per share, exceeding estimates, though its revenue fell 7.8% from last year. 该公司的高股利收益率为7.36%,但付款比率为122%,可能无法持续。 The company offers a high dividend yield of 7.36%, but has a payout ratio of 122%, which may not be sustainable. Pfizer的股票被评为“机动购买”,目标价格为29.17美元。 Pfizer's stock is rated a "Moderate Buy" with a target price of $29.17.